Tirzepatide

Tirzepatide is a 39-amino acid synthetic peptide developed as a dual agonist for glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, featuring a C20 fatty diacid side chain conjugation that extends its pharmacokinetic profile.

• Length: 39 amino acids
• Targets: Dual GLP-1/GIP agonist
• Key Feature: Fatty diacid for half-life extension
• Research Applications: Incretin synergy, multi-hormone metabolic effects
• Common Models: Rodent glycemic/obesity studies, pancreatic function assays
• Mechanistic Interests: Dual receptor engagement, insulin secretion enhancement

It is used in research to examine synergistic incretin hormone signaling, glycemic regulation mechanisms, energy balance modulation, and combined hormonal influences on metabolism in experimental diabetes, obesity, and related metabolic models.

This product is sold for research use only.